XML 60 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Consolidated Revenues Attributable to Products or Services (Details) - Revenue Benchmark [Member] - Product Concentration Risk [Member]
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 100.00% 100.00%
Pharma Services [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 42.00% 27.00%
Discontinued Operations [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 58.00% 73.00%